A detailed history of Cibc World Market Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 17,665 shares of ABCL stock, worth $48,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,665
Previous 18,165 2.75%
Holding current value
$48,755
Previous $54,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.39 - $3.49 $1,195 - $1,745
-500 Reduced 2.75%
17,665 $46,000
Q2 2024

Aug 07, 2024

BUY
$2.73 - $4.73 $8,026 - $13,906
2,940 Added 19.31%
18,165 $54,000
Q1 2024

May 13, 2024

BUY
$4.29 - $5.97 $3,646 - $5,074
850 Added 5.91%
15,225 $69,000
Q4 2023

Feb 13, 2024

SELL
$3.91 - $5.93 $48,601 - $73,709
-12,430 Reduced 46.37%
14,375 $82,000
Q3 2023

Nov 13, 2023

SELL
$4.6 - $7.95 $47,379 - $81,885
-10,300 Reduced 27.76%
26,805 $123,000
Q2 2023

Aug 11, 2023

SELL
$5.66 - $7.59 $10,754 - $14,421
-1,900 Reduced 4.87%
37,105 $240,000
Q1 2023

May 12, 2023

BUY
$7.31 - $11.18 $38,962 - $59,589
5,330 Added 15.83%
39,005 $294,000
Q4 2022

Feb 13, 2023

BUY
$9.48 - $14.52 $14,220 - $21,780
1,500 Added 4.66%
33,675 $341,000
Q3 2022

Nov 10, 2022

BUY
$9.2 - $13.68 $52,439 - $77,976
5,700 Added 21.53%
32,175 $318,000
Q2 2022

Aug 10, 2022

SELL
$5.72 - $10.65 $13,871 - $25,826
-2,425 Reduced 8.39%
26,475 $282,000
Q1 2022

May 12, 2022

SELL
$7.46 - $14.14 $82,455 - $156,289
-11,053 Reduced 27.67%
28,900 $282,000
Q4 2021

Feb 14, 2022

SELL
$12.99 - $17.73 $484,358 - $661,098
-37,287 Reduced 48.27%
39,953 $571,000
Q3 2021

Nov 12, 2021

BUY
$14.85 - $21.34 $135,090 - $194,129
9,097 Added 13.35%
77,240 $1.55 Million
Q2 2021

Aug 12, 2021

BUY
$20.19 - $34.17 $220,434 - $373,068
10,918 Added 19.08%
68,143 $1.5 Million
Q1 2021

May 11, 2021

BUY
$23.29 - $53.2 $1.33 Million - $3.04 Million
57,225 New
57,225 $1.94 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.